Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Biotie maintains global rights to BTT-1023 for inflammatory diseases

April 22, 2010

Genentech and Seattle Genetics to renew antibody-drug conjugate collaboration

April 22, 2010

Silence Therapeutics and AstraZeneca extend siRNA delivery collaboration

April 22, 2010

Abbott completes tender offer to finalize acquisition of Facet Biotech

April 21, 2010

Southern Research and Vivo Biosciences sign promotion and comarketing agreement

April 21, 2010

AMRI and Navigen enter into research collaboration

April 20, 2010

Impax amends copromotion agreement with Wyeth

April 19, 2010

Genocea and U.S. military to collaborate on development of malaria vaccine

April 19, 2010

Celgene and Agios collaborate to develop cancer metabolism programs

April 19, 2010

Aveo receives milestone payment from Biogen Idec for erbB-3 antibody program

April 16, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.